Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Antiaging Quantum Living (AAQL) EBIT (2020 - 2025)

Antiaging Quantum Living (AAQL) has disclosed EBIT for 6 consecutive years, with -$272239.0 as the latest value for Q4 2025.

  • Quarterly EBIT fell 36.93% to -$272239.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$641108.0 through Dec 2025, up 26.51% year-over-year, with the annual reading at -$789959.0 for FY2025, 91.27% down from the prior year.
  • EBIT hit -$272239.0 in Q4 2025 for Antiaging Quantum Living, down from -$51222.0 in the prior quarter.
  • In the past five years, EBIT ranged from a high of -$1520.0 in Q3 2022 to a low of -$272239.0 in Q4 2025.
  • Historically, EBIT has averaged -$92122.2 across 5 years, with a median of -$29727.0 in 2023.
  • Biggest five-year swings in EBIT: soared 80.08% in 2022 and later tumbled 3519.77% in 2024.
  • Year by year, EBIT stood at -$19310.0 in 2021, then surged by 64.93% to -$6772.0 in 2022, then tumbled by 1333.74% to -$97093.0 in 2023, then tumbled by 104.77% to -$198814.0 in 2024, then tumbled by 36.93% to -$272239.0 in 2025.
  • Business Quant data shows EBIT for AAQL at -$272239.0 in Q4 2025, -$51222.0 in Q3 2025, and -$138203.0 in Q2 2025.